Literature DB >> 10328652

Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide.

N Ogura1, H Nagura, Y Abiko.   

Abstract

BACKGROUND: Urokinase-type plasminogen activator receptor (uPAR) presenting on the cell surface with glycosylphosphatidylinositol (GPI) anchor is a key component in the plasminogen activator (PA)-plasmin system and plays a critical role in extracellular matrix degradation. It is believed that uPAR serves to localize and accelerate this generation system. In this study, we examined the levels of both uPA and uPAR in human gingival fibroblasts treated with Porphyromonas gingivalis lipopolysaccharide (LPS).
METHODS: Human gingival fibroblasts from the seventh to tenth doubling passages were plated at 5x10(4) cells per well in 24-well plates. The confluent-stage cells were cultured for 24 hours in alpha-MEM medium containing 2% fetal calf serum, after which they were incubated with P. gingivalis LPS. PA activity was measured using plasminogen and plasmin substrate S2251.
RESULTS: PA activity in the cell lysate was increased by LPS and reached maximum at 1 microg/ml LPS after being incubated for 8 hours. PA activity released by phosphatidylinositol-specific phospholipase C, which detaches the GPI anchor, was also increased by LPS. The activity was inhibited by amiloride, which is a specific inhibitor for uPA. LPS increased the protein and mRNA levels of both uPA and uPAR in gingival fibroblasts.
CONCLUSIONS: These findings suggest that increase of the uPAR level by LPS may play an important role in the progression of periodontal diseases through pericellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328652     DOI: 10.1902/jop.1999.70.4.402

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.

Authors:  Roselind S Lam; Neil M O'Brien-Simpson; John A Hamilton; Jason C Lenzo; James A Holden; Gail C Brammar; Rebecca K Orth; Yan Tan; Katrina A Walsh; Andrew J Fleetwood; Eric C Reynolds
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

2.  Cytokine responses to treponema pectinovorum and treponema denticola in human gingival fibroblasts.

Authors:  C S Nixon; M J Steffen; J L Ebersole
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  The Periodontal Pathogen Porphyromonas gingivalis Preferentially Interacts with Oral Epithelial Cells in S Phase of the Cell Cycle.

Authors:  Firas B Al-Taweel; C W Ian Douglas; Simon A Whawell
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

4.  u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.

Authors:  Youcheng Ding; Hui Zhang; Zhuqing Zhou; Mingan Zhong; Qiliang Chen; Xujing Wang; Zhenggang Zhu
Journal:  World J Surg Oncol       Date:  2012-12-12       Impact factor: 2.754

5.  The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathway.

Authors:  Yosuke Kanno; Akira Ishisaki; Mei Miyashita; Osamu Matsuo
Journal:  Immun Inflamm Dis       Date:  2016-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.